The aim of the Education Committee (EC) is to coordinate ESOT’s efforts to advance multidisciplinary education for transplant professionals at all career levels and to contribute to their professional development.
The Basic Science Committee promotes scientific issues and transplantation research within ESOT. An active basic science community and an efficient translation of innovation into the clinic are crucial for the future of transplantation medicine.
The European Transplant Allied Healthcare Professionals (ETAHP) reaches out to allied healthcare professionals throughout Europe in order to ensure the best care possible for all transplant patients, with the aim to optimize patient outcomes.
The Young Professionals in Transplantation (YPT) is the Network for Junior Transplant professionals of ESOT, representing all young transplant clinicians and scientists who are beginning a career in transplantation and organ donation.
The mission of ECTORS is to provide a forum for discussing and stimulating novel developments in the fields of cellular therapies in organ transplantation, organ regeneration and generation of new organs from stem cells and biomaterials.
ECTTA is the forum for experience exchange on treatment of patients with end-stage heart and lung failure. Our aim is to improve outcomes for the patients.
EDTCO aims to support health care professionals to provide clinically effective programmes on organ and tissue donation, procurement and transplantation.
EKITA is the Organ Expert Section of ESOT on kidney transplantation in Europe, providing a forum for kidney transplantation professionals to exchange scientific information and views aimed at providing the best service to European patients .
The European Liver and Intestine Transplant Association (ELITA), previously known as the European Liver Transplant Association (ELTA), is a section of ESOT. Its membership represents the expertise on liver and intestinal transplantation in Europe.
ELPAT is a European platform that brings continuity and progress in European research and dialogue on "Ethical, Legal and Psychosocial Aspects of organ Transplantation". ELPAT currently consists of over 160 experts from more than 25 European countries.
EPITA is established to provide a forum for those working in the field of pancreas and islet of Langerhans transplantation or any other alternative form of beta cell replacement in Europe, to exchange scientific information and views related primarily to providing the best service for patients in Europe requiring pancreas or islet transplantation.
VCA has opened a new era in the field of transplantation, reconstructive and restorative surgery. This Section brings together 10 representatives of major European teams at the forefront in this field.
The webinar “Challenges and scientific advancements in biomarkers in paediatric transplantation” of the relaunched ESOT Basic Science Committee webinar series aims to build links between ESOT and IPTA. As such, we invite professionals with clinical and scientific expertise in paediatric kidney transplantation to present and discuss the unique challenges of translational research in this vulnerable cohort. Biomarkers for the early detection of rejection in kidney transplant recipients are urgently needed. They promise timely and refined diagnosis to facilitate early treatment, and especially in pediatric patients to reduce diagnostic burden from repeated biopsies. However, unique challenges lay in the extrapolation, translation, analytical, and clinical study and application in pediatric transplant recipients. In partnership with IPTA we aim to address and discuss these unique challenges and opportunities in pediatric transplantation. If well received, we plan to build on this partnership to add future conjoint webinars to the ESOT Basic Science Committee webinar series.
Need:
Biomarkers for the early detection of rejection in kidney transplant recipients are urgently needed to provide timely treatment. Studies in adult and pediatric recipients are emerging, exemplified by the biomarker donor-derived cell-free DNA. However, pediatric specifics and unique challenges to biomarker research in this population are seldom discussed or addressed. These unique challenges and opportunities will be discussed during this webinar coming from the results of the largest cross-sectional donor-derived cell-free DNA study in adult and pediatric recipients and finally addressing diagnostic performance of donor-derived cell-free DNA for (pediatric) research and clinical application.
Educational objectives:
Stimulating thought, generating scientific discourse, building links between ESOT and IPTA.
Programme:
Please fill up the Webinar Registration to get an email for your direct access link.
